Portal Innovations retweetledi

Merck's $6.7B deal to acquire Terns is good news for small biotech companies, says @portalinno CEO @JohnLFlavin. He gives his read on biopharma M&A and what to expect in dealmaking this year. $MRK $TERN
cnbc.com/video/2026/03/…
English





















